Two months after a cyberattack disrupted its operations, Boston Scientific heads into its third-quarter earnings call on October 28 with investors watching for the full financial impact.
The medical-device maker detected the attack on August 25, 2026. A network outage cut access to some operating systems and business applications, leaving the company unable to manufacture products or ship customer orders, according to its filings with the Securities and Exchange Commission. Staff at manufacturing facilities in Cork, Ireland, were sent home.
By September 8, Boston Scientific said a substantial part of its distribution network had been restored, its sterilization facilities were operational along with most manufacturing sites, and backlogged orders were shipping above normal levels. It gave no timeline for full recovery.
The company said it is unlikely to meet the net sales growth and adjusted earnings guidance it issued in late July for the third quarter and full year, and that the incident is likely to have a material impact on results, though it does not expect an effect on its long-term financial condition. No group has claimed responsibility, and the company has not said whether ransomware was involved.
Why manufacturers should pay attention
Modern factories depend on the same IT networks as the rest of the business. When order management, scheduling and quality systems go offline, production can stop even if the machines themselves are untouched. That makes tested recovery plans and separation between office and plant networks a board-level issue.
Sources: HIPAA Journal, MedTech Dive.
Image: illustration created for AABEAT TV. It does not depict the people, places or products named in this story.
